Outcomes in patients treated with taxane regimen after immune checkpoint inhibitors failure in advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Guillemois, S. [1 ]
Seegers, V. [2 ]
Molinier, O. [3 ]
Masson, P. [4 ]
Capitain, O. [5 ]
Bigot, F. [6 ]
机构：
[1] ICO Site Paul Papin, Dept Med Oncol, Angers, France
[2] ICO, Biometr Unit, St Herblain, France
[3] Ctr Hosp Mans, Dept Resp Dis, Le Mans, France
[4] Ctr Hosp Cholet, Pneumol, Cholet, France
[5] Ctr Paul Papin, Dept Med Oncol, Angers, France
[6] ICO Inst Cancerol Ouest Site Paul Papin, Dept Med Oncol, Angers, France
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.088
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70P
引用
收藏
页码：S1402 / S1403
页数：2
相关论文
共 50 条
  • [1] Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Chai, Rong
    Yin, Yipengchen
    Cai, Xuwei
    Fu, Xiaolong
    Zhang, Qin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Hyperprogressive Disease in Advanced Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
    Lo Russo, G.
    Signorelli, D.
    Proto, C.
    Galli, G.
    Prelaj, A.
    Ferrara, R.
    Sommariva, M.
    Moro, M.
    Cancila, V.
    Ganzinelli, M.
    Brich, S.
    Sangaletti, S.
    Pruneri, G.
    Tripodo, C.
    Colombo, M. P.
    Rivoltini, L.
    Balsari, A.
    Sozzi, G.
    Boeri, M.
    Garassino, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S245 - S245
  • [3] Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Ayala de Miguel, P.
    Lopez Gallego, J.
    Gorospe Garcia, I.
    Illan Varella, A.
    Rivera Vargas, P. R.
    Posada Restrepo, A.
    Borrega Garcia, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Outcomes with chemotherapy for metastatic non-small cell lung cancer (mNSCLC) in patients previously treated with immune checkpoint inhibitors (CPI).
    Elnair, Radowan
    Chang, Guy Vin
    Powell, Steven Francis
    Sumey, Christopher Joseph
    Bleeker, Jonathan Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [6] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [7] Immune Checkpoint Inhibitors and Additional Local Treatment in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
    Atmaca, A.
    Wetzel, S.
    Van Kampen, M.
    Salam, S.
    Somuncuoglu, G.
    Veit, S.
    Jaeger, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S357 - S358
  • [8] Clinical Outcomes in Metastatic Non-small Cell Lung Cancer Harboring BRAF Mutations Treated With Immune Checkpoint Inhibitors
    Garcia-Illescas, D.
    Callejo, A.
    Iranzo, P.
    Assaf, J. D.
    Molina, G.
    Priano, I.
    Valdivia, A.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Cedres, S.
    Carbonell, C.
    Frigola, J.
    Amat, R.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S378 - S379
  • [9] Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer
    Cunha, R.
    Fernandes, M.
    Abreu, S.
    Oliveira, C.
    Dias, J.
    Alves, S.
    Rodrigues, A.
    Oliveira, J.
    Pousa, M. I.
    Soares, M.
    Azevedo, I.
    ANNALS OF ONCOLOGY, 2020, 31 : S1432 - S1432
  • [10] Deep learning model to predict clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Elkrief, A.
    Phan, K.
    Di Jorio, L.
    Simpson, R.
    Chasse, M.
    Malo, J.
    Richard, C.
    Kosyakov, M.
    Chandelier, F.
    Kafi, K.
    Routy, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S885 - S885
12345